| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Assimilating new therapeutic interventions into clinical practice: How does hypertension compare with other therapeutic areas?
|
Carruthers, S.George
|
|
1999
|
138 |
3S |
p. S256-S260
5 p.
|
article
|
| 2 |
Current clinical practice in hypertension: The EISBERG (Evaluation and Interventions for Systolic Blood Pressure Elevation—Regional and Global) project
|
Swales, John D.
|
|
1999
|
138 |
3S |
p. S231-S237
7 p.
|
article
|
| 3 |
Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials
|
He, Jiang
|
|
1999
|
138 |
3S |
p. S211-S219
9 p.
|
article
|
| 4 |
Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile
|
Kannel, William B.
|
|
1999
|
138 |
3S |
p. S205-S210
6 p.
|
article
|
| 5 |
Influence of arterial pulse and reflected waves on blood pressure and cardiac function
|
London, Gérard M.
|
|
1999
|
138 |
3S |
p. S220-S224
5 p.
|
article
|
| 6 |
Integrated approaches to management of hypertension: Promoting treatment acceptance
|
McInnes, Gordon T.
|
|
1999
|
138 |
3S |
p. S252-S255
4 p.
|
article
|
| 7 |
Introduction
|
Julius, Stevo
|
|
1999
|
138 |
3S |
p. S203-S204
2 p.
|
article
|
| 8 |
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data
|
Brooks, David P.
|
|
1999
|
138 |
3S |
p. S246-S251
6 p.
|
article
|
| 9 |
Risk reduction associated with lowering systolic blood pressure: Review of clinical trial data
|
Hall, W.Dallas
|
|
1999
|
138 |
3S |
p. S225-S230
6 p.
|
article
|
| 10 |
Safety and efficacy of eprosartan, a new angiotensin II receptor blocker
|
Shusterman, Neil H.
|
|
1999
|
138 |
3S |
p. S238-S245
8 p.
|
article
|
Journal description